Radiopharmaceuticals in prostate cancer - radium-223 episode 1

Episode 1 May 12, 2021 00:30:53
Radiopharmaceuticals in prostate cancer - radium-223 episode 1
COR2ED Medical Education
Radiopharmaceuticals in prostate cancer - radium-223 episode 1

May 12 2021 | 00:30:53

/

Show Notes

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss the latest developments in the field of radiopharmaceuticals and their use in Prostate Cancer. They are also joined by guest speaker Dr. Neal Shore (Carolina Urologic Research Center, North Carolina, USA).

In this first episode, the experts focus on the alpha emitter, Radium-223 which received regulatory approval on the basis of the phase 3 ALSYMPCA trial in patients with metastatic castration resistant prostate cancer (mCRPC) and symptomatic bone metastases. They consider mechanism of action and discuss key results from the trial and the safety profile.

The experts also review the ERA-223 and PEACE-III randomised trials which investigated the use of Radium-223 in combination with next generation androgen receptor inhibitors (ARIs). A number of real-world evidence studies are also reviewed as the experts consider where radium-223 fits into the overall treatment sequence for mCRPC patients. Radiation safety and general considerations for delivering therapy with radiopharmaceuticals are also discussed.

Other Episodes

Episode 2

February 07, 2022 00:24:43
Episode Cover

PARP inhibitors in prostate cancer: What nurses need to know

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria...

Listen

Episode 2

July 22, 2021 00:22:14
Episode Cover

Women & Girls Bleed Too: Diagnosing Bleeding Disorders - Episode 2

In this second episode of the podcast series Women and Girls Bleed Too, Haematologist Dr. Roseline d’Oiron (Reference Centre for Haemophilia and RBD, Bicêtre...

Listen

Episode 14

June 20, 2023 00:23:12
Episode Cover

Breast Cancer : Oral SERDs in ER+ breast cancer. Episode 1 - efficacy and safety and treatment landscape

COR2ED Medical Education: In this podcast, the experts give an overview of  the EMERALD trial  and present elacestrant as the first, and currently only,...

Listen